Valuation

What Is a Healthtech Company Worth in 2026?

Written by Tania Kozar Published September 10, 2026 Deal data as of September 10, 2026

The data answer

The ProCloser Tech M&A Deal Index tracked 106 healthtech acquisitions announced in 2026, each documented to a public source. 14 disclosed a price; the median disclosed value is $102M. That median describes the visible top of the market, because disclosure skews toward large transactions. What your company is worth depends on the drivers below, and the honest way to estimate it is against real comparable deals plus your own numbers in the valuation calculator.

What the 2026 deal data shows

106

Tracked 2026 healthtech deals
ProCloser Deal Index, primary-source documented

$102M

Median disclosed value
Across 14 deals that published a price

82%

Strategic buyers
Share of deals with identified buyer type

Healthtech valuations hinge on reimbursement exposure and compliance posture. Software sold to providers on subscription trades like vertical SaaS; anything touching claims, clinical data or patient billing carries regulatory diligence that changes both timeline and price.

What actually moves the number

Revenue model: subscription software versus reimbursement-linked revenue
HIPAA and data-handling posture, verified in diligence
Integration depth with EHR systems and payer workflows
Evidence of clinical or financial outcomes customers can defend

Deals here take longer than plain software transactions; plan the diligence file early.

How to get a real estimate

Three steps beat any rule of thumb. First, run your revenue, EBITDA and sector through the ProCloser valuation calculator for an indicative range. Second, look at actual comparable transactions in the deal index rather than survey multiples. Third, remember that the spread between a bilateral offer and a competitive process is usually larger than the spread between valuation methods; our advisor rankings cover who runs those processes for companies like yours.

Want a Number for Your Business?

Run the calculator for an indicative range, or tell us your sector, size and timeline and we will match you with vetted advisors who can value it properly. Free to sellers, no retainer required.

Run the Valuation Calculator →

Frequently Asked Questions

What is the average sale price of a healthtech company in 2026?

Across 106 tracked 2026 healthtech acquisitions in the ProCloser Tech M&A Deal Index, 14 disclosed a price, with a median disclosed value of $102M. Treat that number carefully: companies that disclose skew large and public. Most founder-scale deals never publish a price, so the true market median sits well below the disclosed one.

Who buys healthtech companies?

In tracked 2026 transactions, strategic acquirers accounted for roughly 82% of healthtech deals with an identified buyer type, with private equity taking most of the rest. 17 of the 106 tracked deals crossed a border, so a well-run process usually includes foreign buyers.

How do I estimate what my healthtech business is worth?

Start from your revenue quality rather than a headline multiple: recurring share, retention, margin and growth set which comp band applies. Then pressure-test against real transactions rather than survey data. The ProCloser deal index tracks every announced 2026 healthtech deal with sources, and our valuation calculator gives an indicative range from your revenue, EBITDA and sector.

Why do disclosed deal values overstate what typical companies sell for?

Because disclosure is selective. Press releases publish prices when a public company, large sponsor or regulator requires it, which concentrates disclosure among the biggest transactions. Founder-scale deals routinely close without a published number. Any median built on disclosed values describes the visible top of the market, not the middle.

ProCloser.ai is not a registered investment adviser, broker-dealer or financial planner, and nothing on this page is investment, legal or tax advice. Rankings are editorially determined from publicly available information under the ProCloser TrustRank methodology; positions are never sold, and any sponsored placement is clearly labeled. ProCloser may receive compensation when you connect with an advisor through our matching service. See our Advertiser Disclosure.